ProShare Advisors LLC Purchases 163,689 Shares of Intuitive Surgical, Inc. $ISRG

ProShare Advisors LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 36.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 618,213 shares of the medical equipment provider’s stock after purchasing an additional 163,689 shares during the quarter. Intuitive Surgical makes up 0.6% of ProShare Advisors LLC’s holdings, making the stock its 24th largest position. ProShare Advisors LLC’s holdings in Intuitive Surgical were worth $350,131,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Radnor Capital Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at about $228,000. Prossimo Advisors LLC bought a new position in Intuitive Surgical in the 4th quarter valued at about $209,000. HighTower Advisors LLC raised its holdings in Intuitive Surgical by 2.8% in the 4th quarter. HighTower Advisors LLC now owns 200,450 shares of the medical equipment provider’s stock valued at $113,527,000 after acquiring an additional 5,447 shares during the period. Envestnet Portfolio Solutions Inc. raised its holdings in Intuitive Surgical by 7.9% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 46,820 shares of the medical equipment provider’s stock valued at $26,517,000 after acquiring an additional 3,447 shares during the period. Finally, Wisconsin Capital Management LLC raised its holdings in Intuitive Surgical by 0.7% in the 4th quarter. Wisconsin Capital Management LLC now owns 7,094 shares of the medical equipment provider’s stock valued at $4,018,000 after acquiring an additional 47 shares during the period. 83.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research analyst reports. Truist Financial lowered their price target on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a report on Wednesday, April 15th. Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. The Goldman Sachs Group increased their price target on shares of Intuitive Surgical from $609.00 to $621.00 and gave the company a “buy” rating in a report on Wednesday, April 22nd. Bank of America lowered their price target on shares of Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a report on Monday. Finally, Piper Sandler lowered their target price on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $579.33.

Intuitive Surgical Trading Up 4.5%

Shares of ISRG opened at $439.92 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $417.74 and a 12 month high of $603.88. The firm’s 50 day moving average is $462.50 and its 200-day moving average is $513.03. The stock has a market capitalization of $155.80 billion, a PE ratio of 53.32, a P/E/G ratio of 3.36 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. During the same period last year, the firm earned $1.81 earnings per share. The business’s revenue for the quarter was up 23.0% on a year-over-year basis. Equities research analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total transaction of $51,864.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Mark Brosius sold 2,362 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the transaction, the senior vice president directly owned 3,554 shares in the company, valued at $1,772,308.72. This represents a 39.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 5,647 shares of company stock valued at $2,760,359. 0.60% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.